Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Leucogen   
Auth. number : EU/2/09/096
Active substance : Feline leukaemia vaccine (inactivated)
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AA - Inactivated viral vaccines
Chemical substance: QI06AA01 - feline leukaemia virus
(See WHO ATCvet Index)
Indication: Active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.
Marketing Authorisation Holder: Virbac
1ère Avenue - 2065 m - L.I.D., 06516 Carros CEDEX, France
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/06/2009 Centralised - Authorisation EMEA/V/C/144 (2009)5019 of 17/06/2009
16/06/2014 Centralised - Renewal EMEA/V/C/144/R/2 (2014)4027 of 12/06/2014
11/12/2014 Centralised - Variation EMEA/V/C/144/WS/639
Updated with Decision(2015)8601 of 27/11/2015
01/12/2015 Centralised - Yearly update (2015)8601 of 27/11/2015
21/12/2016 Centralised - Variation EMEA/V/C/144/IG/724
Updated with Decision(2017)9113 of 20/12/2017
22/12/2017 Centralised - Yearly update (2017)9113 of 20/12/2017